Allergan (AGN) Isn't Going to Buy Gilead (GILD) - Bloomberg's Gadfly

September 22, 2016 10:55 AM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Allergan (NYSE: AGN) isn't going to buy Gilead Sciences (NASDAQ: GILD), in the opinion of Bloomberg's Gadfly. Comments follow recent speculation and bullish comments from a Gabelli analyst. The articles highlights the staggering amount of debt to raise and carry, potential inversion difficulties, and lack of interest in a transformative acquisition.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Rumors, Trader Talk

Related Entities

Definitive Agreement

Add Your Comment